ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "FDA Approval: Adjuvant Alectinib for Resected NSCLC"
Episode Synopsis
In the wake of the FDA's approval of alectinib for resected non-small cell lung cancer, Lung Cancer Considered host Dr. Narjust Florez and Dr. Benjamen Solomon discuss this development and take a deeper look at the ALINA trial, which played an important role in the drug's approval.
More episodes of the podcast Lung Cancer Considered
LCC in Hungarian: WCLC 2025 Highlights
31/10/2025
LCC in Greek: WCLC 2025 Highlights
10/10/2025
LCC in Arabic: WCLC 2025 Highlights
03/10/2025
Lung Cancer Considered: Targeting EGFR NSCLC
03/10/2025
In God we trust